JP6732736B2 - デングウィルス複製阻害剤としての一または二置換インドール誘導体 - Google Patents

デングウィルス複製阻害剤としての一または二置換インドール誘導体 Download PDF

Info

Publication number
JP6732736B2
JP6732736B2 JP2017513061A JP2017513061A JP6732736B2 JP 6732736 B2 JP6732736 B2 JP 6732736B2 JP 2017513061 A JP2017513061 A JP 2017513061A JP 2017513061 A JP2017513061 A JP 2017513061A JP 6732736 B2 JP6732736 B2 JP 6732736B2
Authority
JP
Japan
Prior art keywords
compound
methoxyphenyl
chloro
mmol
enantiomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017513061A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017531619A (ja
JP2017531619A5 (enExample
Inventor
ケステレイン，バート，ルドロフ，ロマニー
ボンファンティ，ジャン−フランセス
ヨンカー，ティム，ヒューゴ，マリア
ラボワソン，ピエール，ジャン−マリー，ベルナード
バディオット，ドロテ，アリス，マリ‐イブ
マーチャンド，アルノ，ディディエ，エム
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Katholieke Universiteit Leuven
Original Assignee
Katholieke Universiteit Leuven
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54199687&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP6732736(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Katholieke Universiteit Leuven filed Critical Katholieke Universiteit Leuven
Publication of JP2017531619A publication Critical patent/JP2017531619A/ja
Publication of JP2017531619A5 publication Critical patent/JP2017531619A5/ja
Application granted granted Critical
Publication of JP6732736B2 publication Critical patent/JP6732736B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2017513061A 2014-10-01 2015-09-30 デングウィルス複製阻害剤としての一または二置換インドール誘導体 Active JP6732736B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP14187374 2014-10-01
EP14187374.5 2014-10-01
EP15159164.1 2015-03-16
EP15159164 2015-03-16
PCT/EP2015/072551 WO2016050841A1 (en) 2014-10-01 2015-09-30 Mono- or di-substituted indole derivatives as dengue viral replication inhibitors

Publications (3)

Publication Number Publication Date
JP2017531619A JP2017531619A (ja) 2017-10-26
JP2017531619A5 JP2017531619A5 (enExample) 2018-11-08
JP6732736B2 true JP6732736B2 (ja) 2020-07-29

Family

ID=54199687

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017513061A Active JP6732736B2 (ja) 2014-10-01 2015-09-30 デングウィルス複製阻害剤としての一または二置換インドール誘導体

Country Status (32)

Country Link
US (1) US9944598B2 (enExample)
EP (1) EP3201176B1 (enExample)
JP (1) JP6732736B2 (enExample)
KR (1) KR102478311B1 (enExample)
CN (1) CN107001264B (enExample)
AU (1) AU2015326930B2 (enExample)
BR (1) BR112017006299A2 (enExample)
CA (1) CA2959573A1 (enExample)
CL (1) CL2017000782A1 (enExample)
CY (1) CY1121874T1 (enExample)
DK (1) DK3201176T3 (enExample)
EA (1) EA032546B1 (enExample)
ES (1) ES2714074T3 (enExample)
HR (1) HRP20190199T1 (enExample)
HU (1) HUE041888T2 (enExample)
IL (1) IL251396A0 (enExample)
LT (1) LT3201176T (enExample)
MA (1) MA40768B1 (enExample)
ME (1) ME03360B (enExample)
MX (1) MX2017004299A (enExample)
PH (1) PH12017500571A1 (enExample)
PL (1) PL3201176T3 (enExample)
PT (1) PT3201176T (enExample)
RS (1) RS58461B1 (enExample)
SG (1) SG11201702463YA (enExample)
SI (1) SI3201176T1 (enExample)
SM (1) SMT201900162T1 (enExample)
TW (1) TWI681951B (enExample)
UA (1) UA121119C2 (enExample)
UY (1) UY36340A (enExample)
WO (1) WO2016050841A1 (enExample)
ZA (1) ZA201702301B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019511502A (ja) * 2016-04-01 2019-04-25 ヤンセン ファーマシューティカルズ，インコーポレーテッド デングウイルス複製阻害剤としての置換インドール化合物誘導体

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201116559D0 (en) 2011-09-26 2011-11-09 Univ Leuven Kath Novel viral replication inhibitors
GB201305376D0 (en) 2013-03-25 2013-05-08 Univ Leuven Kath Novel viral replication inhibitors
US9453018B2 (en) 2014-10-01 2016-09-27 Bristol-Myers Squibb Company Pyrimidinones as factor XIa inhibitors
JP6701185B2 (ja) * 2014-10-01 2020-05-27 ヤンセン ファーマシューティカルズ，インコーポレーテッド デングウィルス複製阻害剤としての一または二置換インドール
DK3201206T3 (da) 2014-10-01 2019-12-16 Merck Patent Gmbh Borsyrederivater
JOP20160086B1 (ar) 2015-05-08 2021-08-17 2 Katholieke Univ Leuven Ku Leuven Research And Development مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JOP20160198B1 (ar) 2015-09-16 2022-03-14 Janssen Pharmaceuticals Inc مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JO3633B1 (ar) 2015-09-16 2020-08-27 Katholieke Univ Leuven Ku Leuven Research & Development مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
ES2882488T3 (es) 2016-03-31 2021-12-02 Janssen Pharmaceuticals Inc Derivados de indol sustituidos como inhibidores de la replicación vírica del dengue
MA44498A (fr) 2016-03-31 2019-02-06 Janssen Pharmaceuticals Inc Dérivés d'indoline substituée utilisés en tant qu'inhibiteurs de la réplication du virus de la dengue
JOP20170069B1 (ar) * 2016-04-01 2021-08-17 1 Janssen Pharmaceuticals Inc مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JOP20180025B1 (ar) 2017-03-31 2021-08-17 Janssen Pharmaceuticals Inc مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JOP20180026A1 (ar) 2017-03-31 2019-01-30 Univ Leuven Kath مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
EP3630723B1 (en) 2017-05-22 2022-08-24 Janssen Pharmaceuticals, Inc. Substituted indoline derivatives as dengue viral replication inhibitors
DK3630724T3 (da) * 2017-05-22 2021-07-26 Janssen Pharmaceuticals Inc Substituerede indolinderivater som inhibitorer af virusreplikation af denguevirus
WO2024252254A1 (en) * 2023-06-05 2024-12-12 Zydus Lifesciences Limited Novel compounds to treat viral infections

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2448410A4 (en) * 2009-06-30 2013-12-18 Siga Technologies Inc TREATMENT AND PREVENTION OF INFECTIONS WITH THE DENGUE VIRUS
GB201116559D0 (en) * 2011-09-26 2011-11-09 Univ Leuven Kath Novel viral replication inhibitors
JOP20160086B1 (ar) * 2015-05-08 2021-08-17 2 Katholieke Univ Leuven Ku Leuven Research And Development مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JOP20160198B1 (ar) * 2015-09-16 2022-03-14 Janssen Pharmaceuticals Inc مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019511502A (ja) * 2016-04-01 2019-04-25 ヤンセン ファーマシューティカルズ，インコーポレーテッド デングウイルス複製阻害剤としての置換インドール化合物誘導体
JP7007290B2 (ja) 2016-04-01 2022-01-24 ヤンセン ファーマシューティカルズ，インコーポレーテッド デングウイルス複製阻害剤としての置換インドール化合物誘導体

Also Published As

Publication number Publication date
EA032546B1 (ru) 2019-06-28
KR102478311B1 (ko) 2022-12-15
PL3201176T3 (pl) 2019-06-28
LT3201176T (lt) 2019-03-25
PH12017500571A1 (en) 2017-08-30
MA40768B1 (fr) 2019-03-29
UY36340A (es) 2016-04-01
BR112017006299A2 (pt) 2018-01-16
US20170298017A1 (en) 2017-10-19
HUE041888T2 (hu) 2019-06-28
UA121119C2 (uk) 2020-04-10
AU2015326930A1 (en) 2017-03-16
JP2017531619A (ja) 2017-10-26
MA40768A (fr) 2017-09-08
DK3201176T3 (en) 2019-03-25
SG11201702463YA (en) 2017-04-27
ZA201702301B (en) 2018-12-19
EP3201176B1 (en) 2018-12-12
CN107001264A (zh) 2017-08-01
PT3201176T (pt) 2019-03-04
HRP20190199T1 (hr) 2019-04-05
AU2015326930B2 (en) 2020-03-26
SI3201176T1 (sl) 2019-05-31
EP3201176A1 (en) 2017-08-09
ES2714074T3 (es) 2019-05-27
MX2017004299A (es) 2017-07-19
IL251396A0 (en) 2017-05-29
ME03360B (me) 2019-10-20
EA201790758A1 (ru) 2017-07-31
KR20170063802A (ko) 2017-06-08
CA2959573A1 (en) 2016-04-07
TWI681951B (zh) 2020-01-11
CY1121874T1 (el) 2020-10-14
WO2016050841A1 (en) 2016-04-07
WO2016050841A9 (en) 2016-06-02
CL2017000782A1 (es) 2017-11-03
RS58461B1 (sr) 2019-04-30
TW201630879A (zh) 2016-09-01
SMT201900162T1 (it) 2019-05-10
CN107001264B (zh) 2021-06-15
US9944598B2 (en) 2018-04-17

Similar Documents

Publication Publication Date Title
JP6732736B2 (ja) デングウィルス複製阻害剤としての一または二置換インドール誘導体
JP7451626B2 (ja) デングウイルス複製阻害剤としての一または二置換インドール誘導体
JP6701185B2 (ja) デングウィルス複製阻害剤としての一または二置換インドール
JP6830438B2 (ja) デングウィルス複製阻害剤としてのインドール誘導体
JP7045984B2 (ja) デングウイルス複製阻害剤としての一または二置換インドール誘導体
US20180256545A1 (en) Mono- or Di-Substituted Indole Derivatives As Dengue Viral Replication Inhibitors
HK1241874A1 (en) Mono- or di-substituted indole derivatives as dengue viral replication inhibitors

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170901

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180928

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180928

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190618

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20190620

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190918

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191105

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20191224

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20200319

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200608

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20200623

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20200708

R150 Certificate of patent or registration of utility model

Ref document number: 6732736

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250